136 related articles for article (PubMed ID: 36242752)
1. The combination of early identification, chemotherapy, and autologous stem cell transplantation obtained favorable outcomes in unilateral primary adrenal lymphoma: A case report.
Huang L; Shuai X; Zhang T; Kuang P; Zhang D; Chen T; Tian H; Xiang B; Ren Y
Endocrine; 2023 Jan; 79(1):49-54. PubMed ID: 36242752
[TBL] [Abstract][Full Text] [Related]
2. Systemic and prophylactic intrathecal chemotherapy for primary adrenal lymphoma: A retrospective study of 20 case reports.
Yuan L; Sun L; Bo J; Wang Q; Zhao Y
Medicine (Baltimore); 2019 Jun; 98(24):e15662. PubMed ID: 31192909
[TBL] [Abstract][Full Text] [Related]
3. Successful autologous peripheral blood stem cell transplantation for a patient with primary adrenal lymphoma with hemophagocytic syndrome.
Uehara T; Yokota A; Onoda M; Yamamoto K; Terano T
Clin Lymphoma Myeloma; 2008 Jun; 8(3):184-7. PubMed ID: 18650184
[TBL] [Abstract][Full Text] [Related]
4. Primary adrenal lymphoma: 3 case reports with different outcomes.
Spyroglou A; Schneider HJ; Mussack T; Reincke M; von Werder K; Beuschlein F
Exp Clin Endocrinol Diabetes; 2011 Apr; 119(4):208-13. PubMed ID: 21374545
[TBL] [Abstract][Full Text] [Related]
5. Primary Adrenal Lymphoma: Two Case Series From China.
Zeng J; Yan F; Chen Y; Zang L; Chen K; Lyu Z; Dou J; Mu Y; Lin M; Yang G
Front Endocrinol (Lausanne); 2021; 12():778984. PubMed ID: 35154000
[TBL] [Abstract][Full Text] [Related]
6. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
7. [Effective combined modality therapy for a patient with primary adrenal lymphoma].
Shirao S; Kuroda H; Kida M; Watanabe H; Matsunaga T; Niitsu Y; Konuma Y; Hirayama Y; Kohda K
Rinsho Ketsueki; 2006 Mar; 47(3):204-9. PubMed ID: 16629485
[TBL] [Abstract][Full Text] [Related]
8. Autologous hematopoietic stem cell transplantation as first-line consolidation therapy can improve the prognosis of diffuse large B-cell lymphoma with high expression of MYC protein.
Hu K; Gao JJ; Li QH; Tian L; Wan W; Zhao W; Wang JJ; Fu L
Kaohsiung J Med Sci; 2019 Jul; 35(7):425-431. PubMed ID: 31050117
[TBL] [Abstract][Full Text] [Related]
9. Primary bilateral adrenal non-Hodgkin's Burkitt-like lymphoma: a rare cause of primary adrenal insufficiency. Case report and literature review.
Dobrinja C; Trevisan G; Liguori G
Tumori; 2007; 93(6):625-30. PubMed ID: 18338503
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy Experience.
Rassy E; Danu A; Ibrahim T; Lazarovici J; Ghez D; Michot JM; Arfi-Rouche J; Rossignol J; Vergé V; Dartigues P; Ribrag V
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e373-e380. PubMed ID: 33277224
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy with autologous stem cell transplantation following systemic chemotherapy, prophylactic intrathecal methotrexate, and radiotherapy prevents relapse and improves the outcome of advanced stage primary testicular lymphoma even with cardiac involvement.
Lee S; Yamauchi T; Kinoshita K; Imamura S; Kamiya K
J Clin Exp Hematop; 2017 Oct; 57(2):64-68. PubMed ID: 28883219
[TBL] [Abstract][Full Text] [Related]
12. R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 study.
Kagami Y; Yamamoto K; Shibata T; Tobinai K; Imaizumi Y; Uchida T; Shimada K; Minauchi K; Fukuhara N; Kobayashi H; Yamauchi N; Tsujimura H; Hangaishi A; Tominaga R; Suehiro Y; Yoshida S; Inoue Y; Suzuki S; Tokuhira M; Kusumoto S; Kuroda J; Yakushijin Y; Takamatsu Y; Kubota Y; Nosaka K; Morishima S; Nakamura S; Ogura M; Maruyama D; Hotta T; Morishima Y; Tsukasaki K; Nagai H
Cancer Sci; 2020 Oct; 111(10):3770-3779. PubMed ID: 32767806
[TBL] [Abstract][Full Text] [Related]
13. Primary bilateral adrenal diffuse large B-cell lymphoma demonstrating adrenal failure.
Horiguchi K; Hashimoto K; Hashizume M; Masuo T; Suto M; Okajo J; Handa H; Kaneko Y; Yokoo H; Sasaki A; Okada S; Yamada M; Tsukamoto N; Nojima Y; Nakazato Y; Mori M
Intern Med; 2010; 49(20):2241-6. PubMed ID: 20962443
[TBL] [Abstract][Full Text] [Related]
14. Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma.
Kim YR; Yoon SO; Kim SJ; Cheong JW; Chung H; Lee JY; Jang JE; Kim Y; Yang WI; Min YH; Kim JS
Ann Hematol; 2020 Sep; 99(9):2149-2157. PubMed ID: 32390113
[TBL] [Abstract][Full Text] [Related]
15. Primary adrenal lymphoma: a systematic review.
Rashidi A; Fisher SI
Ann Hematol; 2013 Dec; 92(12):1583-93. PubMed ID: 23771429
[TBL] [Abstract][Full Text] [Related]
16. Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era.
Biswas T; Dhakal S; Chen R; Hyrien O; Bernstein S; Friedberg JW; Fisher RI; Liesveld J; Phillips G; Constine LS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):79-85. PubMed ID: 19647953
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation.
Choi MK; Kang ES; Kim DW; Ko YH; Seok H; Park JH; Pyo DH; Hoon Lim D; Kim SJ; Kim WS
Int J Hematol; 2013 Sep; 98(3):346-54. PubMed ID: 23868695
[TBL] [Abstract][Full Text] [Related]
18. Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.
Sehn LH; Antin JH; Shulman LN; Mauch P; Elias A; Kadin ME; Wheeler C
Blood; 1998 Jan; 91(2):717-23. PubMed ID: 9427731
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes after autologous stem cell transplant for patients with relapsed or refractory diffuse large B-cell lymphoma who failed initial rituximab, cyclophosphamide, adriamycin, vincristine, and prednisone therapy compared to patients who failed cyclophosphamide, adriamycin, vincristine, and prednisone.
Chen YB; Hochberg EP; Feng Y; Neuberg D; Rawal B; Motyckova G; Fisher DC; McAfee SL; Spitzer TR; Lacasce AS
Leuk Lymphoma; 2010 May; 51(5):789-96. PubMed ID: 20367136
[TBL] [Abstract][Full Text] [Related]
20. A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma.
Wagner-Johnston ND; Goy A; Rodriguez MA; Ehmann WC; Hamlin PA; Radford J; Thieblemont C; Suh C; Sweetenham J; Huang Y; Sullivan ST; Vandendries ER; Gisselbrecht C
Leuk Lymphoma; 2015; 56(10):2863-9. PubMed ID: 25707288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
